Click here for more sample CPC practice exam questions with Full Rationale Answers

Practice Exam

Click here for more sample CPC practice exam questions and answers with full rationale

Practice Exam

CPC Practice Exam and Study Guide Package

Practice Exam

What makes a good CPC Practice Exam? Questions and Answers with Full Rationale

CPC Exam Review Video

Laureen shows you her proprietary “Bubbling and Highlighting Technique”

Download your Free copy of my "Medical Coding From Home Ebook" at the top right corner of this page

Practice Exam

2018 CPC Practice Exam Answer Key 150 Questions With Full Rationale (HCPCS, ICD-9-CM, ICD-10, CPT Codes) Click here for more sample CPC practice exam questions with Full Rationale Answers

Practice Exam

Click here for more sample CPC practice exam questions and answers with full rationale

TAVR Approved Clinical Study

Transcatheter Aortic Valve Replacement
Transcatheter aortic valve replacement (TAVR – also known as TAVI or transcatheter aortic valve implantation) is a new technology for use in treating aortic stenosis. A bioprosthetic valve is inserted percutaneously using a catheter and implanted in the orifice of the native aortic valve.
CMS issued a Medicare National Coverage Determination on May 1, 2012 which allows coverage of TAVR under Coverage with Evidence Development (CED) with certain conditions.  The complete determination is available on our website.  As part of CED, we are identifying below the Medicare approved registry and Medicare approved clinical trials which have been reviewed and determined to meet the requirements of coverage.
Clinical Study Approvals
Study Title: REPRISE IV: Repositionable Percutaneous Replacement of Stenotic Aortic Valve through Implantation of LOTUS Edge Valve System in IntermediatE Surgical Risk Subjects
Sponsor: Boston Scientific
Clinicaltrials.gov number: NCT03618095
Investigational Device Exemption (IDE) Number: G160209
CMS Approval Date: 10/16/2018
Study Title: Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)
Sponsor: Medtronic Cardiovascular
Clinicaltrials.gov number: NCT03635424
Investigational Device Exemption (IDE) Number: G160022
CMS Approval Date: 10/10/2018
Study Title: A Prospective, Single-arm, Controlled, Multicenter Study to Establish the Safety and Effectiveness of the CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement
Sponsor: Edwards Lifesciences
Clinicaltrials.gov number: NCT03517436
Investigational Device Exemption (IDE) Number: G180045
CMS Approval Date: 07/05/2018
Study Title: Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement
Sponsor: Medstar Health Research Institute
Clinicaltrials.gov number: NCT03557242
Investigational Device Exemption (IDE) Number: G150207
CMS Approval Date: 06/28/2018
Study Title: Transfemoral Replacement of Aortic Valve with HLT MeriDIAN Valve Early Feasibility Trial (RADIANT)
Sponsor: HLT Inc.
Clinicaltrials.gov number: NCT02799823
Investigational Device Exemption (IDE) Number: G160091
CMS Approval Date: 06/29/2017
Study Title: Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
Sponsor: Edwards Lifesciences
Clinicaltrials.gov number: NCT03042104
Investigational Device Exemption (IDE) Number: G160259
CMS Approval Date: 06/05/2017
Study Title: Edwards SAPIEN 3 TVH PARTNER 3 Aortic Valve-in-Valve Trial
Sponsor: Edwards Lifesciences
Clinicaltrials.gov number: NCT03003299
Investigational Device Exemption (IDE) Number: G150278
CMS Approval Date: 01/17/2017
Study Title: Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure: a randomized trial (TAVR UNLOAD)
Sponsor: Cardiovascular Research Foundation
ClinicalTrials.gov Number: NCT02661451
Investigational Device Exemption (IDE) Number: G150252
CMS Approval Date: 09/06/2016
Study Title: JenaValve AS EFS study
Sponsor: JenaValve Technology, Inc.
ClinicalTrials.gov Number: NCT02732691
Investigational Device Exemption (IDE) Number: G150035
CMS Approval Date: 07/20/2016
Study Title: JenaValve AR EFS study
Sponsor: JenaValve Technology, Inc.
ClinicalTrials.gov Number: NCT02732704
Investigational Device Exemption (IDE) Number: G150035
CMS Approval Date: 07/12/2016
Study Title: Low Risk TAVR
Sponsor: MedStar Cardiovascular Research Institute
ClinicalTrials.gov Number: NCT02628899
Investigational Device Exemption (IDE) Number: G150207
CMS Approval Date: 07/01/2016
Study Title: Medtronic CoreValve Evolut R US Clinical Study: Evolut 34R Addendum
Sponsor: Medtronic
ClinicalTrials.gov Number: NCT02746809
Investigational Device Exemption (IDE) Number: G140059
CMS Approval Date: 06/06/2016
Study Title: Medtronic Transcatheter Aortic Valve Replacement (TAVR) 2.0 US Clinical Study
Sponsor: Medtronic
ClinicalTrials.gov Number: NCT02738853
Investigational Device Exemption (IDE) Number: G160039
CMS Approval Date: 05/31/2016
Study Title: SAPIEN 3 THV PARTNER 3 Trial
Sponsor: Edwards Lifesciences
ClinicalTrials.gov Number : NCT02675114
Investigational Device Exemption (IDE) Number: G150278
CMS Approval Date: 03/17/2016
Study Title: Medtronic Transcatheter Aortic Valve Replacement (TAVR) with the Medtronic Transcatheter Aortic Valve Replacement System (TAVR) in patients at Low Risk for Surgical Aortic Valve Replacement (SAVR)
Sponsor: Medtronic
ClinicalTrials.gov Number: NCT02701283
Investigational Device Exemption (IDE) Number: G160022
CMS Approval Date: 03/17/2016
Study Title:  REPRISE III: REpositionable Percutaneous Replacement of Stenotic Aortic Valve through Implantation of Lotus™ Valve System – Randomized Clinical Evaluation
Sponsor:  Boston Scientific Corporation
ClinicalTrials.gov Number : NCT02202434
Investigational Device Exemption (IDE) Number:  G140090
CMS Approval Date: 09/13/2014
Study Title:  The Medtronic CoreValve™ Evolut R™ Clinical Study
Sponsor:  Medtronic
ClinicalTrials.gov Number: NCT02207569  
Investigational Device Exemption (IDE) Number: G140059
CMS Approval Date: 07/24/2014
Study Title: TranScatheter Aortic Valve RepLacement System a US Pivotal Trial (SALUS)
Sponsor:  Direct Flow Medical, Inc.
ClinicalTrials.gov Number: NCT02163850
Investigational Device Exemption (IDE) Number: G120160
CMS Approval Date: 06/05/2014
Study Title: Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO) Interventional Trial
Sponsor: St. Jude Medical
ClinicalTrials.gov Number: NCT02000115
Investigational Device Exemption (IDE) Number: G120263
CMS Approval Date: 03/25/2014
Study Title: SALUS Trial: The Direct Flow Medical Transcatherter Aortic Valve Replacement System US Feasibility Trial
Sponsor: Direct Flow Medical
ClinicalTrials.gov Number: NCT01932099
Investigational Device Exemption (IDE) Number: G120160
CMS Approval Date: 09/25/2013
Study Title: Alternative Access Approaches for Transcatheter Aortic Valve Replace (TAVR) in Inoperable Patients with Aortic Stenosis
Sponsor: The Society of Thoracic Surgeons and The American College of Cardiology Foundation
ClinicalTrials.gov Number: NCT01787084
Investigational Device Exemption (IDE) Number: G120291
CMS Approval Date: 02/07/2013
Study Title:  Medtronic CoreValve Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)
Sponsor: Medtronic
ClinicalTrials.gov Number:  NCT01586910
Investigational Device Exemption (IDE) Number:  G120169
CMS Approval Date:  09/05/2012
Study Title: Medtronic CoreValve Expanded Use Study
Sponsor: Medtronic
ClinicalTrials.gov Number: NCT01675440
Investigational Device Exemption (IDE) Number: G100012
CMS Approval Date: 09/11/2012
Study Title:  PARTNER II Trial (Placement of AoRTic TraNscathetER Valves Trial II)
Sponsor: Edwards Lifesciences
ClinicalTrials.gov Number:  NCT01314313
Investigational Device Exemption (IDE) Number:  G090216
CMS Approval Date: 05/01/2012
Study Title: Medtronic CoreValve U.S. Pivotal Trial
Sponsor: Medtronic
ClinicalTrials.gov Number: NCT01240902
Investigational Device Exemption (IDE) Number:  G100012
CMS Approval Date: 05/01/2012
Study Title:  Medtronic CoreValve Continued Access Study
Sponsor: Medtronic
ClinicalTrials.gov Number: NCT01531374
Investigational Device Exemption (IDE) Number:  G100012
CMS Approval Date: 05/01/2012


Coding Ahead

Query letters for my 2018 CANPC coding study guide and upcoming 2019 coding book

Vino C. Mody Jr., M.D., Lic., Ph.D.
6154 Black Mallard Place
El Paso, TX 79932
678-427-6511 cell; 915-642-4269 home
[email protected]

February 2, 2018
Dear Agent:

Please allow me to introduce my recently completed non-fiction book—CANPC Essentials for Accurate and Efficient Medical Coding for Anesthesia and Pain Management—a self-help book aimed at readers who are pursuing a career in anesthesia and pain management coding. The primary target audience is those who are about to take the Certified Anesthesia and Pain Management Coder (CANPCTM) examination, but the book is expected to be a useful and relevant reference book for coders already working in this field.
CANPC Essentials for Accurate and Efficient Medical Coding for Anesthesia and Pain Management weighs in at approximately 23,000 words and is fully complete. My previous publications include 100 conference abstracts and 25 original scientific papers published during my eight-year tenure as a clinical researcher at the Karolinska Institutet in Sweden. I also served as editor of three different clinical research journals while at Karolinska.

I have worked in the healthcare field for 15 years at different hospitals in the U.S. and Sweden. I have valid medical coding specialist certificates from the University of Georgia and U.S. Career Institute and several important coding and billing certifications (COC, CPC, CCS-P, CANPC, CCVTC, 4Med CICP, CMAA, and CBCS). I taught coding and worked as a coder for three years in health care institutes and with coding consultants in El Paso, Texas, and I worked in the medical administration department at Mesa Hills Hospital in El Paso, Texas, where I resolved billing issues by performing coding (including surgery coding), medical auditing, medical transcription, and quality data analysis. I have a medical degree from Emory University School of Medicine in Atlanta, Georgia, and received training from Yale-New Haven Hospital (Waterbury, CT) and Brown University/Lifespan. I have a Licentiate degree and Ph.D. from Karolinska Institutet in Stockholm, Sweden, and eight years of experience in ophthalmology research and teaching in ophthalmology, surgery, medicine, and pediatrics. I have drawn heavily on both my coding and teaching experience in developing CANPC Essentials for Accurate and Efficient Medical Coding for Anesthesia and Pain Management as a training and teaching tool for future anesthesia coders.

I have researched the work and interests of your agency, and I believe that my book fits well with the type of published works that you promote. I have therefore included an outline, a synopsis, and a copy of the completed manuscript for your perusal.

I thank you for your time and consideration.
Sincerely,

Vino C. Mody Jr.
——————————————————————————————————————————————————————————————-
Vino C. Mody Jr.
6154 Black Mallard Place
El Paso, TX 79932
678-427-6511
[email protected]

Ernst E. Roberts, President
El Paso Community College
9050 Viscount Boulevard
El Paso, TX 79925

May 1, 2019

Dear Agent:

Please allow me to introduce my recently completed non-fiction book—A Medical Study Guide and Training Tool—a training guide aimed at readers who are pursuing a career in medical coding. The primary target audience is those who are about to take the Certified Anesthesia and Pain Management Coder (CANPCTM) examination, but the book is expected to be a useful and relevant reference book for coders already working in this field.
A Medical Study Guide and Training Tool is approximately 45,000 words in length and is fully complete. It is intended as a 2019 update of my previous book CANPC Essentials for Accurate Efficient Medical Coding for Anesthesia and Pain Management and includes important strategies for Medicare coding. My previous publications include 25 original scientific papers and 100 conference abstracts. I also served as editor of three different clinical research journals while working at the Karolinska Institutet in Sweden, where I obtained my Licentiate degree and PhD conducting research in ophthalmology, surgery, medicine, and pediatrics.

I have worked in the healthcare field for 15 years at different hospitals in the U.S. and Sweden. I have valid medical coding specialist certificates from the University of Georgia and U.S. Career Institute and several important coding and billing certifications (COC, CPC, CCS-P, CANPC, CCVTC, CEDC, 4Med CICP, RMC, CMAA, CBCS, CNPR, CRMC). I taught coding and have three years of experience as a coder and consultant in several health care institutes. I am a CANPC/CCVTC coding lecturer for American Academy of Professional Coders currently. My previous employment was in the medical administration department at Mesa Hills Hospital in El Paso, Texas, where I resolve billing issues involving coding, medical auditing, medical transcription, and quality data analysis. I have capitalized on both my coding and teaching experience in developing A Medical Study Guide and Training Tool as a training and teaching tool for future medical coders.

I have researched the work and interests of your agency, and I believe that my book fits well with the type of published works that you promote. I have therefore included an outline, a synopsis, and a copy of the completed manuscript for your perusal.

I thank you for your time and consideration.

Sincerely,

Vino C. Mody Jr.

Medical Billing and Coding Forum

Myocardial Perfusion Study

I been coding 93016/93018 and wasn’t sure if I should be including CPt 78451 or 78452… want to make sure im capturing this correctly on the professional side :( HELP!

Cardiologist: A
Myocardial Perf. Study
Myocardial Perf.
Date of Procedure: 04/16/19
Indication:
negative troponins
CP
Findings:
chart reviewed
Impression/conclusion:
In a fasting state, the patient was taken to the nuclear medicine department where he was monitored continuously. A
stress adenosine was performed according to protocol. The patient had SOB and flushing during the infusion and
remained hemodynamically stable. Baseline EKG SR J point elevation inferior and lateral leads without acute changes
during the test. Nuclear images pending.

Tech:
NM CARDIAC STRESS SCAN W/DRUGS
NUCLEAR MEDICINE MYOCARDIAL PERFUSION SCAN

History: Chest pain.

Procedure:

The patient underwent stress testing with infusion of Lexiscan, using
established protocol, with injection of 32 mCi of 99m Tc Cardiolite.

A resting myocardial perfusion imaging study was also performed, with
injection of 4.3 mCi of thallium 201 chloride.

Single photon emission computed tomography was employed to generate
tomographic images of the left ventricle, stress and resting and gated
rest and stress SPECT was also acquired to evaluate wall motion and
ejection fraction.

Findings:

There are focal areas of decreased perfusion on the stress portion of
the exam in the inferior wall of the left ventricle with improved
perfusion on the rest portion of the exam to suggest reversible
ischemia.

Sum stress score is 3, sum rest score is0 and sum difference score is
3.

The left ventricle demonstrates normal wall motion. The estimated
ejection fraction is 68%.

There is no left ventricular dilatation.

IMPRESSION:

1. Reversible ischemia in the inferior wall of the left ventricle.

2. Normal left ventricular wall motion.

3. Calculated ejection fraction of 68%.

Medical Billing and Coding Forum

Sleep Study (for Cardio patient) w/Pulmonology interpretation

Cardio meets with patient and gives equipment with direction of use 95800 with Mod -TC
Patient brings back equipment and Cardio downloads report

Pulm picks up report and does interpretation 95800 with Mod -26

But, if Total Recording Time (TRT) is less than 6 hours, Pulm also adds a Mod -52 for reduced services.
The question remains if Cardio needs to add Mod -52 to their charges even if their work was done when handing off equipment.

We cannot find definite answer to this and want to bill correctly.

Medical Billing and Coding Forum

Home Sleep Study done in Skilled Nursing Facility. Need advice

Hi,

Has anyone ever encountered billing for a HST when the patient is in a SNF. We are a private group practice and not sure if we could bill this and be reimbursed. The insurance is Medicare.

Any advice would be greatly appreciated. We typically bill 95806 with POS 12.

Thank you,
Michelle

Medical Billing and Coding Forum

Joint Commission refutes AO conflict of interest study

A study that found independent hospital accreditation carries no real benefit for patient outcomes has garnered a formal rebuttal from The Joint Commission, which argues the researchers reached faulty conclusions due to a number of methodological flaws.

HCPro.com – Briefings on Accreditation and Quality